At the Outsourcing in Clinical Trials Conference in New England, experts shared insights on how the US clinical trial and pharmaceutical space could keep up
As biosimilars enter the psoriasis market, key opinion leaders anticipate a shift in patient preference from IL-23 therapies to IL-17 therapies due to pricing and
In an exclusive interview with Pharmaceutical Technology, Dr Kenneth Getz attributed the wave of pharma layoffs to patent cliffs and uncertainty due to the upcoming
At the Outsourcing in Clinical Trials Conference in New England, the CBP warned attendees of the common legal pitfalls researchers make in transporting material for
At the Outsourcing in Clinical Trials Conference in New England, the associate director of a UAE contract research organisations shared the opportunities for clinical research
At the Outsourcing in Clinical Trials conference in New England, Andarix Pharmaceuticals’ CEO shared the uses of social media for improved rare disease trial patient
As AI makes clinical operations more streamlined, companies will have to adapt their workforces to the new technology, say experts at the Outsourcing in Clinical
ImmunoPrecise Antibodies’ CEO highlighted a growing trend in rabbit monoclonal antibody platform therapeutics, detailing the benefits of the modality. Credit: Richard Constantinoff via Getty Images.
Sources from WuXi Biologics and WuXi Apptec say the companies are considering selling some of their operations as the Biosecure act moves through the US
The European Commission has approved Johnson and Johnson’s Yuvanci for pulmonary arterial hypertension, offering the first single-pill treatment option to European patients. Credit: andreswd via